CopyMark Law Group
4.9/5
Drawing for FLEXEON

USPTO serial 99306823

FLEXEON

Reviewed by CopyMark Law Group

Reg. 8363406Status 700Registered
Filing date
Status date
Registration date
Jul 28, 2026
Examiner
SCHRADER, BRITTANY A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FLEXEON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kirk M. Miles

Kirk M. Miles The Webb Law FirmOne Gateway Center420 Fort Duquesne Boulevard, Suite 1200Pittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes for the treatment and relieve of muscle, joint and tendon pain and for treatment of aches and pains caused by bruises, arthritis, nerve pain, sprains and strains; chemico-pharmaceutical preparations for the treatment and relieve of muscle, joint and tendon pain and for treatment of aches and pains caused by bruises, arthritis, nerve pain, sprains and strains; dermatological plaster for the transdermal administration of pharmaceutical preparations; medical plasters; medical dressings; medicinal preparations for the treatment and relieve of muscle, joint and tendon pain and for treatment of aches and pains caused by bruises, arthritis, nerve pain, sprains and strainsACTIVE—
010Apparatus and instruments for administering medicines, especially those including layered arrangements or structures for use in the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medical apparatus and instruments for administration of pharmaceuticals and biotechnological molecules using layered structures, including in the form of plasters to be used on the skinACTIVE—
042Consultancy in the field of laboratory experiments; consultancy related to pharmacology; consultancy in the field of pharmaceutical research; consultancy related to research and development in the field of therapeutical methods; research and development in the field of pharmacology and biotechnology; pharmaceutical research; research and development services for the pharmaceutical industry; providing information relating to the results of clinical studies on pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 28, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 9, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 9, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 11, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2025DOCKASSIGNED TO EXAMINER—
Dec 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 28, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance